An analytical framework outlining the determinants of HTA recommendations across settings based on primary data collection and primary analysis of secondary data

An analytical framework will be developed outlining the determinants of HTA recommendations across countries based on primary and secondary data with the aim to provide insights on the relevant value concerns of decision makers beyond costs and clinical effects